Donepezil: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
Line 14: | Line 14: | ||
{| class="wikitable" border="1" width="48%" style="text-align:center" | {| class="wikitable" border="1" width="48%" style="text-align:center" | ||
|- | |- | ||
! colspan="7" align="center"| Aceylcholinesterase Inhibitor [[Pharmaceutical_Drugs#Pharmacokinetics_Translated|Pharmacokinetics]]<ref>PMID:17113365</ref><ref>PMID: 19935404</ref><ref>PMID:7605915</ref><ref>PMID:1404819</ref><ref>doi:10.1053/cp.1999.v66.103404001</ref><ref>doi:10.1038/sj.clpt.6100242</ref> | ! colspan="7" align="center"| Aceylcholinesterase Inhibitor [[Pharmaceutical_Drugs#Pharmacokinetics_Translated|Pharmacokinetics]]<ref>PMID:17113365</ref><ref>PMID: 19935404</ref><ref>PMID:7605915</ref><ref>PMID:1404819</ref><ref>doi:10.1053/cp.1999.v66.103404001</ref><ref>doi:10.1038/sj.clpt.6100242</ref> <ref>PMID:12734391</ref> | ||
|- | |- | ||
! Parameter | ! Parameter | ||
Line 67: | Line 67: | ||
! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ||
! 53.6 | ! 53.6 | ||
! | ! 450 | ||
! 181390 | ! 181390 | ||
! 1995 | ! 1995 | ||
! | ! 1080 | ||
|- | |- | ||
! Dosage (mg) | ! Dosage (mg) | ||
! 5 | ! 5 | ||
! 160 | ! 160 | ||
! | ! 6 | ||
! 8 | ! 8 | ||
! 30 | ! 30 |